Growth Metrics

OmniAb (OABI) Share-based Compensation (2022 - 2026)

OmniAb (OABI) reported Share-based Compensation of $3.3 million for Q1 2026, down 19.4% year-over-year from $4.1 million in Q1 2025, and down 7.38% on a QoQ basis from $3.6 million in Q4 2025.

OmniAb (OABI) has 5 years of Share-based Compensation data on file, last reported at $3.3 million in Q1 2026.

  • Quarterly Share-based Compensation fell 19.4% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.0 million (down 24.7% YoY) and the FY2025 annual result came in at $15.8 million, down 26.4% from the prior year.
  • Share-based Compensation slipped to $3.3 million in Q1 2026 per OABI's latest filing, from $3.6 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $6.5 million in Q2 2023 and bottomed at $3.1 million in Q1 2022.
  • The 5-year median for Share-based Compensation is $5.3 million (2022), against an average of $4.9 million.
  • The widest annual swing landed in 2023, when Share-based Compensation surged 92.47%; it then dropped 29.52% in 2025.
  • Tracing OABI's Share-based Compensation over 5 years: stood at $6.0 million in 2022, then decreased by 2.03% to $5.9 million in 2023, then slipped by 13.67% to $5.1 million in 2024, then retreated by 29.52% to $3.6 million in 2025, then declined by 7.38% to $3.3 million in 2026.
  • Per Business Quant, the three latest OABI Share-based Compensation figures stand at $3.3 million (Q1 2026), $3.6 million (Q4 2025), and $4.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 892,057.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 305,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 166.40 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 257.40 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 70.15 Mn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn 3.34 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.34 Mn
Mar 31, 2026 3.34 Mn
Dec 31, 2025 3.61 Mn
Dec 31, 2025 3.61 Mn
Sep 30, 2025 3.96 Mn
Sep 30, 2025 3.96 Mn
Jun 30, 2025 4.11 Mn
Jun 30, 2025 4.11 Mn
Mar 31, 2025 4.14 Mn
Mar 31, 2025 4.14 Mn
Dec 31, 2024 5.12 Mn
Dec 31, 2024 5.12 Mn
Sep 30, 2024 5.31 Mn
Sep 30, 2024 5.31 Mn
Jun 30, 2024 5.38 Mn
Jun 30, 2024 5.38 Mn
Mar 31, 2024 5.70 Mn
Mar 31, 2024 5.70 Mn
Dec 31, 2023 5.93 Mn
Dec 31, 2023 5.93 Mn
Sep 30, 2023 6.31 Mn
Sep 30, 2023 6.31 Mn
Jun 30, 2023 6.53 Mn
Jun 30, 2023 6.53 Mn
Mar 31, 2023 6.06 Mn
Mar 31, 2023 6.06 Mn
Dec 31, 2022 6.05 Mn
Dec 31, 2022 6.05 Mn
Sep 30, 2022 5.28 Mn
Sep 30, 2022 5.28 Mn
Jun 30, 2022 3.85 Mn
Jun 30, 2022 3.85 Mn
Mar 31, 2022 3.15 Mn
Mar 31, 2022 3.15 Mn